2017-11-09 19:25 ET - News Release

Mr. John Miller reports

THC ANNOUNCES ANNUAL GENERAL MEETING RESULTS

THC Biomed Intl Ltd. has released the results of its annual general and special meeting of shareholders held in Vancouver, B.C., on Nov. 7, 2017. At the meeting, the shareholders of the company approved all matters proposed by management.

At the meeting, shareholders voted in favour of electing Hee Jung Chun, Ashish Dave, John Miller and George Smitherman as directors of the company. Wolrige Mahon LLP, chartered accountants, will remain as the auditor for the ensuing year.

"This has been a great year for THC. We are looking forward to the coming year and what the developments in the industry will mean for our growing and expanding company," said John Miller, president and chief executive officer of THC. "I appreciate the shareholders' support, and the entire team here is working diligently to bring THC to its full potential."

About THC Biomed Intl Ltd.

THC's vision is to be on the leading edge of scientific research, development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well positioned to be in the forefront of this rapidly growing industry.